INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Accounts Receivable
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Accounts Receivable of $253.85 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$29.89K, a 135.74% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $421.70K, a 72.20% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$261.17K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $123.21K, a 17.24% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2026 was $253.85K, a 53.93% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2025 was $164.91K, a 21.40% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2024 was $135.84K, a 53.77% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in accounts receivable for fiscal 2023 was $293.86K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$29.89K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $391.81K derived: sum of 2 quarters · filed 2026-08-19 | $130.64K derived: sum of 3 quarters · filed 2026-08-19 | $253.85K 10-K · filed 2026-08-19 | |
| 2026-03-31 | $421.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $160.53K derived: sum of 2 quarters · filed 2026-05-13 | $283.74K 10-Q · filed 2026-05-13 | $367.39K derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-12-31 | -$261.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$137.96K 10-Q · filed 2026-02-12 | -$54.31K derived: sum of 3 quarters · filed 2026-08-19 | $190.58K derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-09-30 | $123.21K 10-Q · filed 2025-11-12 | $206.86K derived: sum of 2 quarters · filed 2026-08-19 | $451.74K derived: sum of 3 quarters · filed 2026-08-19 | $139.25K derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-06-30 | $83.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $328.53K derived: sum of 2 quarters · filed 2026-08-19 | $16.04K derived: sum of 3 quarters · filed 2026-08-19 | $164.91K 10-K · filed 2026-08-19 | |
| 2025-03-31 | $244.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$67.61K derived: sum of 2 quarters · filed 2026-05-13 | $81.26K 10-Q · filed 2026-05-13 | $151.06K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | -$312.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$163.62K 10-Q · filed 2026-02-12 | -$93.82K derived: sum of 3 quarters · filed 2026-02-12 | $3.25K derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-09-30 | $148.87K 10-Q · filed 2025-11-12 | $218.68K derived: sum of 2 quarters · filed 2025-11-12 | $315.74K derived: sum of 3 quarters · filed 2025-11-12 | $11.07K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $69.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $166.87K derived: sum of 2 quarters · filed 2025-08-15 | -$137.81K derived: sum of 3 quarters · filed 2025-08-15 | $135.84K 10-K · filed 2025-08-15 | |
| 2024-03-31 | $97.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$207.61K derived: sum of 2 quarters · filed 2025-05-13 | $66.04K 10-Q · filed 2025-05-13 | $63.85K derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$304.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$31.03K 10-Q · filed 2025-02-13 | -$33.22K derived: sum of 3 quarters · filed 2025-02-13 | -$38.40K derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-09-30 | $273.65K 10-Q · filed 2024-11-07 | $271.46K derived: sum of 2 quarters · filed 2024-11-07 | $266.27K derived: sum of 3 quarters · filed 2024-11-07 | $714.84K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$2.19K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | -$7.37K derived: sum of 2 quarters · filed 2024-09-18 | $441.19K derived: sum of 3 quarters · filed 2024-09-18 | $293.86K 10-K · filed 2024-09-18 | |
| 2023-03-31 | -$5.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $443.38K derived: sum of 2 quarters · filed 2024-05-08 | $296.05K 10-Q · filed 2024-05-08 | $296.05K derived: sum of 4 quarters · filed 2024-05-08 | |
| 2022-12-31 | $448.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | $301.24K 10-Q · filed 2024-02-09 | $301.24K derived: sum of 3 quarters · filed 2024-02-09 | $301.24K derived: sum of 4 quarters · filed 2024-02-09 | |
| 2022-09-30 | -$147.33K 10-Q · filed 2022-11-14 | -$147.33K derived: sum of 2 quarters · filed 2022-11-14 | -$147.33K derived: sum of 3 quarters · filed 2022-11-14 | $527.65K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $0.00 derived: sum of 2 quarters · filed 2022-09-22 | $674.98K derived: sum of 3 quarters · filed 2022-09-22 | -$1.83M 10-K · filed 2022-09-22 | |
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $674.98K derived: sum of 2 quarters · filed 2022-05-16 | -$1.83M 10-Q · filed 2022-05-16 | ||
| 2021-12-31 | $674.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | -$1.83M 10-Q · filed 2022-02-11 | |||
| 2021-09-30 | -$2.50M 10-Q · filed 2022-11-14 | -$1.83M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |